Suppr超能文献

转化生长因子β1作为骨折愈合中的病理生理因素

[TGF-beta1 as a pathophysiological factor in fracture healing].

作者信息

Zimmermann G, Moghaddam A, Reumann M, Wangler B, Breier L, Wentzensen A, Henle P, Weiss S

机构信息

Unfallchirurgische Klinik der Berufsgenossenschaftlichen Unfallklinik, Universität Heidelberg, Ludwig-Guttmann-Strasse 13, 67071 Ludwigshafen, Deutschland.

出版信息

Unfallchirurg. 2007 Feb;110(2):130-6. doi: 10.1007/s00113-006-1199-x.

Abstract

AIM

TGF-beta1 is an important local and systemic regulatory molecule during fracture healing. Various authors have shown differences in the systemic levels of TGF-beta1 over the time taken for bone healing in distraction osteogenesis and osteotomies. Previous studies have shown characteristic differences in the physiological levels of growth factors between normal fracture healing and delayed fracture union. The aim of the present study was to evaluate possible differences in sera levels of patients with normal and delayed union fracture healing.

METHODS

Patients with long bone shaft fractures were recruited prospectively. Peripheral blood samples were collected over a period of 1 year using a standardized time schedule. At the end of the individual's investigation period, TGF-beta1 levels were determined. To achieve a homogeneous collective of patients, only those with a maximum of two fractures were included in the study. After matching for four criteria, we compared patients with normal fracture healing to patients with delayed unions. The fact of delayed union was accepted in case of failed consolidation 4 months after trauma.

RESULTS

During a prospective study period of 1 year, 15 patients with normal fracture healing could be compared to 15 patients suffering from delayed union. By determining the absolute sera levels we found a typical increase of TGF-beta1 up to 2 weeks after fracture in both groups, with a subsequent decrease up to the sixth week after fracture. However, a decline in serum concentration occurred earlier in patients with delayed union, causing significantly lower TGF-beta1 levels in the non-union group 4 weeks after trauma (P=0.00006).

CONCLUSION

Even with a relatively small number of patients, we could show a significant difference in serum concentrations of TGF-beta1 between the investigated groups. If these results can be verified within a larger collective, TGF-beta1 could be used as a predictive cytokine for delayed fracture healing.

摘要

目的

转化生长因子β1(TGF-β1)是骨折愈合过程中一种重要的局部和全身调节分子。不同作者已表明,在牵张成骨和截骨术的骨愈合时间内,TGF-β1的全身水平存在差异。先前的研究表明,正常骨折愈合与延迟骨折愈合之间生长因子的生理水平存在特征性差异。本研究的目的是评估正常愈合和延迟愈合骨折患者血清水平的可能差异。

方法

前瞻性招募长骨干骨折患者。按照标准化时间表在1年内采集外周血样本。在个体研究期结束时,测定TGF-β1水平。为了获得同质化的患者群体,本研究仅纳入最多有两处骨折的患者。在匹配四个标准后,我们将骨折正常愈合的患者与延迟愈合的患者进行了比较。如果创伤后4个月骨折仍未愈合,则认定为延迟愈合。

结果

在为期1年的前瞻性研究期间,可将15例骨折正常愈合的患者与15例延迟愈合的患者进行比较。通过测定血清绝对水平,我们发现两组患者骨折后2周内TGF-β1均有典型升高,随后至骨折后第6周下降。然而,延迟愈合患者血清浓度下降更早,导致创伤后4周骨不连组的TGF-β1水平显著降低(P = 0.00006)。

结论

即使患者数量相对较少,我们仍能显示出研究组之间TGF-β1血清浓度存在显著差异。如果这些结果能在更大的群体中得到验证,TGF-β1可作为延迟骨折愈合的预测性细胞因子。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验